Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 176

The DOI matches its Crossref record.

Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis

Open access
Chen, Jing-Yu, Qiao, Kun, Liu, Feng, Wu, Bo, Xu, Xin, Jiao, Guo-Qing, Lu, Rong-Guo, Li, Hui-Xing, Zhao, Jin, Huang, Jian, Yang, Yi, Lu, Xiao-Jie, Li, Jia-Shu, Jiang, Shu-Yun, Wang, Da-Peng, Hu, Chun-Xiao, Wang, Gui-Long, Huang, Dong-Xiao, Jiao, Guo-Hui, Wei, Dong, Ye, Shu-Gao, Huang, Jian-An, Zhou, Li, Zhang, Xiao-Qin, He, Jian-Xing · 2020 · Chinese Medical Journal

Abstract

Background: Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. Methods: From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores. Results: Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. Conclusions: LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/cm9.0000000000000839

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 176

Metadata

Authors
Chen, J.-Y., Qiao, K., Liu, F., Wu, B., Xu, X., Jiao, G.-Q., Lu, R.-G., Li, H.-X., Zhao, J., Huang, J., Yang, Y., Lu, X.-J., Li, J.-S., Jiang, S.-Y., Wang, D.-P., Hu, C.-X., Wang, G.-L., Huang, D.-X., Jiao, G.-H., Wei, D., Ye, S.-G., Huang, J.-A., Zhou, L., Zhang, X.-Q., & He, J.-X.
Venue
Chinese Medical Journal
Published
2020-04-01
Volume
133
Issue
12
Pages
1390-1396
ISSN
  • 0366-6999 (ISSN-L)
  • 2542-5641
OpenAlex
W3014360862
Cited by
176
References
0
FWCI
32.65
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. https://app.cochat.ai/papers/10.1097/cm9.0000000000000839
The paper
Chen, J.-Y., Qiao, K., Liu, F., Wu, B., Xu, X., Jiao, G.-Q., Lu, R.-G., Li, H.-X., Zhao, J., Huang, J., Yang, Y., Lu, X.-J., Li, J.-S., Jiang, S.-Y., Wang, D.-P., Hu, C.-X., Wang, G.-L., Huang, D.-X., Jiao, G.-H., . . . He, J.-X. (2020). Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. Chinese Medical Journal. https://doi.org/10.1097/cm9.0000000000000839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.